Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

School and Family-Based Obesity Prevention in Pakistani Primary School Children

23 mai 2026 mis à jour par: Qin jiabi, Central South University

School and Family-Based Multifaceted Intervention Program for Preventing Obesity in Primary School Children in Pakistan: A Cluster Randomized Trial

Childhood obesity is increasing rapidly in Pakistan, but there are no large, high-quality studies testing ways to prevent it in schools. This study aims to find out if a 9-month program involving health education, daily physical activity, parent workshops, and regular feedback via WhatsApp or SMS can reduce the number of primary school children who are overweight or obese.

The study is a cluster randomized controlled trial. A total of 26 primary schools in three cities of Punjab (Lahore, Sahiwal, Bahawalnagar) will be randomly assigned to either the intervention group (13 schools) or the control group (13 schools). Children in grades 3, 4, and 5 (aged 6-12 years) will take part.

In the intervention schools, children will receive 18 health education sessions, daily 45 minutes of physical activity, and monthly weight and height checks. Parents will attend three workshops and receive weekly messages and monthly feedback on their child's progress via WhatsApp or SMS. The control schools will continue their usual activities and receive the intervention materials after the study ends.

The main outcome is the change in the proportion of children who are overweight or obese from the start of the study to 9 months later. Secondary outcomes include changes in BMI z-score, waist circumference, physical activity, eating habits, and parents' knowledge. A follow-up assessment at 12 months will check if any benefits last.

Recruitment of schools and children began on January 8, 2026. This is the first cluster randomized trial of its kind in Pakistan. The results will help inform childhood obesity prevention policies in low- and middle-income countries.

Aperçu de l'étude

Description détaillée

Study Design: Two-phase, prospective, parallel-group, cluster-randomized controlled trial (cRCT) with an embedded mixed-methods process evaluation and longitudinal sustainability follow-up. Phase 1: 9-month primary efficacy trial. Phase 2: sustainability assessment at 12 months from baseline (3 months post-intervention).

Setting: 26 primary schools from three cities in Punjab, Pakistan: Lahore, Sahiwal, and Bahawalnagar. These cities represent the socioeconomic and cultural diversity of Punjab, the most populous province of Pakistan.

Randomization: Schools will be randomized 1:1 to intervention or control using computer-generated sequence, stratified by study site. An independent statistician will perform allocation concealment. Outcome assessors and the statistician will be blinded to group assignment. Participants, parents, and school personnel cannot be blinded due to the behavioral nature of the intervention.

Sample Size: 26 schools (13 intervention, 13 control), approximately 90 children per school, total 2,340 children aged 6-12 years in grades 3-5. Sample size calculation assumed a reduction in overweight/obesity prevalence from 36.7% to 26.7% (10% absolute reduction), 80% power, α=0.05, coefficient of variation k=0.15, and 20% attrition buffer.

Intervention (9 months): Developed using the Social Ecological Model and informed by a systematic review (PROSPERO CRD420251242889). Components include:

Child-focused: 18 biweekly sessions (40 min each) of health education (nutrition, physical activity, screen time reduction) and thematic workshops; daily 45 minutes of moderate-to-vigorous physical activity; monthly BMI measurement by trained staff; weekly self-weighing.

Parent-focused: Three workshops covering health messages, WhatsApp training, and feedback on child's progress; encouragement of 30-60 minutes of daily physical activity outside school.

mHealth component: Weekly automated WhatsApp/SMS messages with health tips and behavior tracking; monthly personalized feedback on child's BMI and behavior change. Tiered system for parents without smartphones (SMS or paper booklets).

Fidelity monitoring: Regular field observations, digital engagement logs, and process evaluation.

Control: Schools continue usual curriculum without any structured obesity prevention program. Routine physical education classes, standard school health checks if available, and no structured nutrition education or family engagement activities. After the 12-month follow-up, control schools receive intervention materials.

Outcomes:

Primary: Change in prevalence of overweight and obesity (WHO BMI-for-age z-score: overweight >+1 SD, obesity >+2 SD) from baseline to 9 months.

Secondary: Change in BMI z-score, waist circumference, body fat percentage, moderate-to-vigorous physical activity (days/week ≥60 min), daily screen time, dietary behaviors (sugar-sweetened beverages, fried foods, fast food), obesity-related knowledge (child), parental knowledge and self-efficacy, physical fitness (rope jumps, sit-ups, standing jump, shuttle run), and sustainability of BMI z-score change at 12 months.

Data Collection: Baseline (month 0), mid-point (month 6), post-intervention (month 9), sustainability follow-up (month 12). Anthropometric measurements (height, weight, waist/hip circumference, body fat percentage), blood pressure, physical fitness tests, and validated child/parent questionnaires.

Statistical Analysis: Intention-to-treat principle using generalized linear mixed models accounting for clustering. Primary outcome: binary prevalence analyzed with binomial distribution and logit link, adjusting for baseline values and stratification factors. Secondary continuous outcomes: mixed models with random intercept for school. Missing data <5% will use maximum likelihood; >5% sensitivity with last-value-carried-forward. Subgroup analyses by region, sex, maternal education, baseline BMI status, and primary caregiver. All tests two-sided α=0.05. Analysis will use SAS 9.4.

Process Evaluation: Concurrent mixed-methods evaluation guided by the EPIS framework to assess fidelity, dose, reach, adaptation, barriers, and facilitators. Quantitative metrics (reach, adoption, implementation fidelity, engagement logs) and qualitative interviews/focus groups with principals, teachers, and parents.

Ethics: Approved by Central South University Institutional Review Board (approval number XYGW-2026-18). Written parental consent and child verbal assent required. Data anonymized and securely stored. Study follows Declaration of Helsinki and local guidelines.

Trial Status: Recruitment began December 8, 2025. Planned primary completion September 8, 2026; study completion December 8, 2026.

Funding/Support: National Natural Science Foundation of China (as per proposal page 1). Sponsor: Central South University.

Type d'étude

Interventionnel

Inscription (Estimé)

2340

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Recrutement
        • Selected Primary Schools in Lahore, Sahiwal, and Bahawalnagar, Punjab, Pakistan
        • Contact:
        • Contact:
        • Chercheur principal:
          • Binish Islam

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant

Accepte les volontaires sains

Oui

La description

Inclusion Criteria: Children aged 6-12 years enrolled in grades 3, 4, or 5 of selected primary schools in Lahore, Sahiwal, or Bahawalnagar, Pakistan.

Written informed consent provided by parent or primary caregiver.

Child assent obtained.

Children without any medical conditions that prevent participation in physical activities.

-

Exclusion Criteria: Medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis, or nephritis.

Obesity caused by endocrine diseases or side effects of drugs.

Abnormal physical development (e.g., dwarfism, gigantism).

Physical deformity (e.g., severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg).

Inability to participate in school sport activities.

Weight loss by vomiting or taking drugs during the past three months.

Participation in another obesity prevention or treatment program.

For schools: planned relocation or cancellation within the next two years.

-

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: School and Family-Based Multifaceted Intervention
A 9-month multifaceted program based on the Social Ecological Model. Components: 18 child health education sessions (12 seminars + 6 workshops, 40 min each, biweekly); daily 45 minutes of moderate-to-vigorous physical activity; three parent workshops covering health messages and child progress feedback; monthly BMI monitoring with personalized feedback via WhatsApp/SMS; weekly automated messages for behavior tracking; tiered communication (WhatsApp, SMS, or paper booklets) to ensure all parents can participate. Fidelity monitored through field observations and digital logs.
Behavioral intervention based on the Social Ecological Model, delivered over 9 months. Child components: 18 biweekly sessions (40 min each) of health education (nutrition, physical activity, screen time reduction) and thematic workshops; daily 45 minutes of moderate-to-vigorous physical activity; monthly BMI measurement by trained staff; weekly self-weighing. Parent components: three workshops covering health messages, WhatsApp training, and feedback on child's progress; encouragement of 30-60 minutes daily activity outside school. mHealth: weekly automated WhatsApp/SMS messages with health tips; monthly personalized feedback on child's BMI and behavior change. Tiered system for parents without smartphones (SMS or paper booklets). Fidelity monitoring via field observations and digital logs.
Aucune intervention: Usual Practice (Control)
Schools continue their usual curriculum without any structured obesity prevention program. Routine physical education classes, standard school health checks if available, and no structured nutrition education or family engagement activities related to obesity prevention. After the 12-month follow-up assessment, control schools will be offered the full intervention materials and training

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Prevalence of Overweight and Obesity
Délai: Measured at 9 months from baseline
Combined prevalence of overweight and obesity defined according to WHO child growth standards (BMI-for-age z-score). Overweight: z-score > +1 SD; Obesity: z-score > +2 SD.
Measured at 9 months from baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Qin Jiabi, PHD, Kunming Medical University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Liens utiles

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

8 décembre 2025

Achèvement primaire (Estimé)

8 septembre 2026

Achèvement de l'étude (Estimé)

8 décembre 2026

Dates d'inscription aux études

Première soumission

23 mai 2026

Première soumission répondant aux critères de contrôle qualité

23 mai 2026

Première publication (Réel)

1 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

1 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

23 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Individual participant data (IPD) that underlie the results reported in the main publication will be available after de-identification. Additional documents such as the study protocol, statistical analysis plan, and informed consent form will also be shared. Data will be available beginning 9 months and ending 36 months after article publication to researchers who provide a methodologically sound proposal. Proposals should be directed to the principal investigator (Qin jiabi, email: qinjiabi123@163.com. To gain access, requestors will need to sign a data access agreement.

Délai de partage IPD

IPD and supporting documents will be available beginning 9 months after publication of the main trial results and ending 36 months after article publication.

Critères d'accès au partage IPD

De-identified individual participant data and the supporting documents listed above will be made available to researchers who provide a methodologically sound proposal. Data will be shared for the purposes of meta-analysis, secondary research, or re-analysis. Requests should be directed to the principal investigator (Qin jiabi, email: qinjiabi123@163.com). Requestors will be required to sign a data access agreement to ensure data are used only for the agreed purpose and that no attempts are made to re-identify participants.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE
  • CIF

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner